An anti-seizure drug called levetiracetam was found to have extra benefits for people with Alzheimer’s: Not only did it address Alzheimer’s-related seizures; it appeared…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. Image: Robert Reid and his wife Kimberly….
The amyloid hypothesis—the idea that Alzheimer’s is caused by clumps of proteins known as beta-amyloid—remains unproven. But scientists are holding out hope that monoclonal…
In the future, implantable devices that interface with the brain could help people with severe neurodegenerative movement disorders communicate again through a computer or…
Despite failure after failure in clinical trials, scientists are making progress toward developing investigational treatments for Alzheimer’s. Here’s a primer on all the approved…
In our LiveTalk series, Being Patient spoke with a panel of researchers about the infectious theory of Alzheimer’s, discussing the various viruses and bacteria that…
Cassava Sciences continues to push back on allegations of scientific misconduct around newly released trial data for their investigational Alzheimer’s drug simufilam. Early data…